Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Freshpet (FRPT) Cash & Equivalents (2016 - 2025)

Freshpet (FRPT) has disclosed Cash & Equivalents for 14 consecutive years, with $278.0 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 3.48% to $278.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $278.0 million through Dec 2025, up 3.48% year-over-year, with the annual reading at $278.0 million for FY2025, 3.48% up from the prior year.
  • Cash & Equivalents hit $278.0 million in Q4 2025 for Freshpet, up from $274.6 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $341.0 million in Q1 2021 to a low of $29.7 million in Q1 2022.
  • Historically, Cash & Equivalents has averaged $244.2 million across 5 years, with a median of $263.3 million in 2024.
  • Biggest five-year swings in Cash & Equivalents: crashed 91.28% in 2022 and later soared 1034.02% in 2023.
  • Year by year, Cash & Equivalents stood at $72.8 million in 2021, then skyrocketed by 82.36% to $132.7 million in 2022, then surged by 123.66% to $296.9 million in 2023, then decreased by 9.51% to $268.6 million in 2024, then rose by 3.48% to $278.0 million in 2025.
  • Business Quant data shows Cash & Equivalents for FRPT at $278.0 million in Q4 2025, $274.6 million in Q3 2025, and $243.7 million in Q2 2025.